What is Repligen Corp's Market Cap?

Repligen Corp's Market Cap is $10.0B, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Enterprise Value?

Repligen Corp's Enterprise Value is $9.7B, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Trailing P/E?

Repligen Corp's Trailing P/E is 240.4×, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Price / Sales?

Repligen Corp's Price / Sales is 12.7×, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's EV / Revenue?

Repligen Corp's EV / Revenue is 12.4×, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's EV / EBITDA?

Repligen Corp's EV / EBITDA is 67.8×, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Revenue (TTM)?

Repligen Corp's Revenue (TTM) is $785.1M, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Net Income (TTM)?

Repligen Corp's Net Income (TTM) is $41.5M, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's EBITDA?

Repligen Corp's EBITDA is $143.4M, based on as-reported figures from SEC (XBRL) filings.

What is Repligen Corp's Diluted EPS (TTM)?

Repligen Corp's Diluted EPS (TTM) is 0.74, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Repligen Corp

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S5VNT9

176.93▼ 1.78 (-1.00%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 178.71
Day's Range: 174.90 – 179.54
52-Week Range: 100.99 – 198.87
Volume: 1.1M
Avg Volume: 1.2M

Share Statistics

Shares Outstanding
Employees: 2,000
Exchange: XNAS
Listed: 1986-04-29

Share count as of July 24, 2026

Repligen Corp (RGEN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Repligen Corp (RGEN)

What is Repligen Corp's Market Cap?: Repligen Corp's Market Cap is $10.0B, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Enterprise Value?: Repligen Corp's Enterprise Value is $9.7B, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Trailing P/E?: Repligen Corp's Trailing P/E is 240.4×, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Price / Sales?: Repligen Corp's Price / Sales is 12.7×, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's EV / Revenue?: Repligen Corp's EV / Revenue is 12.4×, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's EV / EBITDA?: Repligen Corp's EV / EBITDA is 67.8×, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Revenue (TTM)?: Repligen Corp's Revenue (TTM) is $785.1M, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Net Income (TTM)?: Repligen Corp's Net Income (TTM) is $41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's EBITDA?: Repligen Corp's EBITDA is $143.4M, based on as-reported figures from SEC (XBRL) filings.
What is Repligen Corp's Diluted EPS (TTM)?: Repligen Corp's Diluted EPS (TTM) is 0.74, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · RGENAs-filed SEC (XBRL) data